NCT ID | NCT03023046 |
Title | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | no |
Sponsors | University of Washington |
Indications | |
Therapies | |
Age Groups: | senior adult |